Artwork

Sisällön tarjoaa Trevor Shewfelt and Kirk Nyquist, Trevor Shewfelt, and Kirk Nyquist. Trevor Shewfelt and Kirk Nyquist, Trevor Shewfelt, and Kirk Nyquist tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

E108 - Terry O'Regan and Brains Bioceutical

44:08
 
Jaa
 

Manage episode 372166910 series 2081912
Sisällön tarjoaa Trevor Shewfelt and Kirk Nyquist, Trevor Shewfelt, and Kirk Nyquist. Trevor Shewfelt and Kirk Nyquist, Trevor Shewfelt, and Kirk Nyquist tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Terry O'Regan has spent his career in the pharmaceutical industry. He has worked for several Big Pharma companies including ones that have developed important treatments for neurological diseases like Multiple Sclerosis.

Terry had heard there was a class of therapeutics for neurological conditions that pharmaceutical companies weren't working on, cannabinoids. Terry kept hearing from neurologists that cannabinoids held great promise for neurological conditions.

Enter Brains Bioceutical. Brains is involved in trials around the world looking at phytochemicals including cannabinoids. Trevor and Terry discuss how cannabis medicine is moving into the pharmaceutical space and how all our "Brains" could be better with the right cannabinoids. Come have a listen.

Brains Bioceutical - website

Terry O'Regan - LinkedIn

Music by:

The Sean Taylor Band - YouTube

Additional Music:

Desiree Dorion desireedorion.com

Marc Clement - Facebook

Transcripts, papers and so much more at: reefermed.ca

  continue reading

145 jaksoa

Artwork
iconJaa
 
Manage episode 372166910 series 2081912
Sisällön tarjoaa Trevor Shewfelt and Kirk Nyquist, Trevor Shewfelt, and Kirk Nyquist. Trevor Shewfelt and Kirk Nyquist, Trevor Shewfelt, and Kirk Nyquist tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Terry O'Regan has spent his career in the pharmaceutical industry. He has worked for several Big Pharma companies including ones that have developed important treatments for neurological diseases like Multiple Sclerosis.

Terry had heard there was a class of therapeutics for neurological conditions that pharmaceutical companies weren't working on, cannabinoids. Terry kept hearing from neurologists that cannabinoids held great promise for neurological conditions.

Enter Brains Bioceutical. Brains is involved in trials around the world looking at phytochemicals including cannabinoids. Trevor and Terry discuss how cannabis medicine is moving into the pharmaceutical space and how all our "Brains" could be better with the right cannabinoids. Come have a listen.

Brains Bioceutical - website

Terry O'Regan - LinkedIn

Music by:

The Sean Taylor Band - YouTube

Additional Music:

Desiree Dorion desireedorion.com

Marc Clement - Facebook

Transcripts, papers and so much more at: reefermed.ca

  continue reading

145 jaksoa

Wszystkie odcinki

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas